Molecular Diagnostics Market Analysis, Geographical Segmentation, Drivers, Forecast

The high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques are some of the key factors driving the growth of this market.

What the Market Looks Like?

Predicted to grow at a CAGR of 8.4% during the forecast period, the Global Molecular Diagnostics Market is estimated to reach USD 11.54 Billion by the end of 2023. In 2018, North America to dominate the market.

On the basis of technology, the market is broadly segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.

On the basis application, the market is broadly segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases.

On the basis of end user, the Molecular Diagnostics Market is broadly segmented into hospitals and academic laboratories, reference laboratories, and other end users. The hospitals and academic laboratories segment is expected to account for the largest share of the market in 2019. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833

What Drives the Market?

The growth of the global market for Molecular Diagnostics is primarily influenced by the following factors:

• High Prevalence of Infectious Diseases and Various Types of Cancers
• Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
• Growth in the Biomarker Identification Market and Advancements in Molecular Techniques

Geographical growth scenario of Molecular Diagnostics Market:

North America is expected to account for the largest share of the global market. The large share of this region is mainly attributed to the high prevalence of infectious diseases and cancers, presence of a highly developed healthcare system and large number of leading national clinical laboratories, easy accessibility to technologically advanced instruments in the region, availability of government funds, and growing applications of molecular diagnostics in genetic disorders and cancer screening.

Leading market players and strategies adopted:

The key players in the Global Molecular Diagnostics Market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.